- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/09 - Streptococcus
Patent holdings for IPC class A61K 39/09
Total number of patents in this class: 1319
10-year publication summary
|
66
|
89
|
84
|
80
|
105
|
92
|
81
|
79
|
98
|
43
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pfizer Inc. | 3391 |
111 |
| Glaxosmithkline Biologicals S.A. | 1651 |
104 |
| Merck Sharp & Dohme LLC | 3756 |
50 |
| Wyeth LLC | 653 |
38 |
| Children's Medical Center Corporation | 1891 |
33 |
| SK Bioscience Co., Ltd. | 120 |
31 |
| Novartis AG | 10709 |
29 |
| Biological e Limited | 71 |
25 |
| Intervet Inc. | 908 |
23 |
| Intervet International B.V. | 1294 |
21 |
| Sanofi Pasteur Inc. | 370 |
17 |
| Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. | 1788 |
14 |
| Vaxcyte, Inc. | 49 |
14 |
| Affinivax, Inc. | 28 |
13 |
| Intervacc AB | 16 |
13 |
| Inventprise, Inc. | 37 |
13 |
| St. Jude Children's Research Hospital | 242 |
12 |
| The UAB Research Foundation | 646 |
12 |
| Merck Sharp & Dohme Corp. | 2190 |
11 |
| The Regents of the University of California | 20137 |
10 |
| Other owners | 725 |